Back to Search
Start Over
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
- Source :
-
International journal of cardiology [Int J Cardiol] 2017 Sep 15; Vol. 243, pp. 290-295. - Publication Year :
- 2017
-
Abstract
- Background: Hypertrophic cardiomyopathy (HCM) is traditionally classified based on a left ventricular outflow tract (LVOT) pressure gradient of 30mmHg at rest or with provocation. There are no data on whether 30mmHg is the most informative cut-off value and whether provoked gradients offer any information regarding outcomes.<br />Methods: Resting and provoked peak LVOT pressure gradients were measured by Doppler echocardiography in patients fulfilling guidelines criteria for HCM. A composite clinical outcome including new onset atrial fibrillation, ventricular tachycardia/fibrillation, heart failure, transplantation, and death was examined over a median follow-up period of 2.1years.<br />Results: Among 536 patients, 131 patients had resting LVOT gradients greater than 30mmHg. Subjects with higher resting gradients were older with more cardiovascular events. For provoked gradients, a bi-modal risk distribution was found. Patients with provoked gradients >90mmHg (HR 3.92, 95% CI 1.97-7.79) or <30mmHg (HR 2.15, 95% CI 1.08-4.29) have more events compared to those with gradients between 30 and 89mmHg in multivariable analysis. The introduction of two cut-off points for provoked gradients allowed HCM to be reclassified into four groups: patients with "benign" latent HCM (provoked gradient 30-89mmHg) had the best prognosis, whereas those with persistent obstructive HCM had the worst outcome.<br />Conclusions: Provoked LVOT pressure gradients offer additional information regarding clinical outcomes in HCM. Applying cut-off points at 30 and 90mmHg to provoked LVOT pressure gradients further classifies HCM patients into low-, intermediate- and high-risk groups.<br /> (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Adult
Aged
Calcium Channel Blockers therapeutic use
Cardiomyopathy, Hypertrophic drug therapy
Cohort Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prospective Studies
Registries
Treatment Outcome
Ventricular Outflow Obstruction drug therapy
Cardiomyopathy, Hypertrophic diagnostic imaging
Cardiomyopathy, Hypertrophic physiopathology
Exercise Test methods
Ventricular Outflow Obstruction diagnostic imaging
Ventricular Outflow Obstruction physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 1874-1754
- Volume :
- 243
- Database :
- MEDLINE
- Journal :
- International journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 28747034
- Full Text :
- https://doi.org/10.1016/j.ijcard.2017.04.039